Antibiotic Prescribing Varies Greatly Among Family Physicians in Canada
A large variance in how family physicians prescribe antibiotics couldn’t be explained by patient characterizations, suggesting a need for improving interventions in antimicrobial stewardship programs.
Fluoroquinolone Antibiotic Risks Outweigh the Benefits in Certain Patients: FDA Safety Warning
The FDA has issued label updates for a handful of fluoroquinolone antibiotics to note the risk of aortic dissections and aortic aneurysms in certain patients.
Mystery E coli Outbreak Likely Linked to Ground Beef
More than 80% of ill individuals reported consuming ground beef prior to falling ill, yet health officials have been unable to pinpoint a common supplier, distributor, or brand responsible for this outbreak.
Contagion® to Report on MAD-ID 2019 in Orlando
Contagion® will be heading to Orlando, Florida, on Wednesday, May 8, 2019, to report on the annual Making a Difference in Infectious Diseases (MAD-ID) 2019 conference.
Health Officials Confirm Presence of "Kissing Bug" in Delaware
Triatoma sanguisugas, an insect also known as a “kissing bug,” can transmit the parasite Trypanosoma cruzi, which causes Chagas disease.
Understanding Barriers, Facilitators Could Boost PrEP Adherence
Understanding barriers and facilitators of PrEP could help improve adherence among young men and transgender women of color, a recent study found.
Candida and C Diff: Rise in Coinfections Could Be the Next Big Health care-Associated Concern
A new review recommends updated guidelines for diagnosing and managing Candida and C diff coinfection.
The ID Pipeline: FDA Activity From the Week of April 28, 2019
Here is a look at infectious disease-related US Food and Drug Administration news from the week of April 28, 2019.
Recalls That Should Be on Your Radar—Week of April 28, 2019
We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.
Top Infectious Disease News of the Week—April 28, 2019
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
Surgical Duration, Patient-Specific Factors Heighten Infection Risk in Knee Replacement
A new analysis of more than half a million knee replacements finds patient-specific factors and certain surgical decisions can make a difference in the rate of infections.
Vampire Facials: Poor Infection Control Results in 2 Cases of HIV
An infamous beauty procedure is causing concern over spa safety failures after 2 clients were diagnosed with HIV.
Final Publication of PARTNER Results Reinforces U=U
The final results of the PARTNER study have been published in the journal The Lancet and confirm that an undetectable viral load on HIV treatment renders an individual sexually non-infectious.
How About Letting Nurses Provide PrEP to Patients?
Difficulties connecting with physicians mean not all people at risk of acquiring HIV have access to PrEP. Putting nurses on the front lines could change that.
Vancomycin-Resistant Enterococci: A Growing Threat
The CDC considers VRE to be a “concerning threat,” and estimates that the bug sickens some 20,000 Americans annually, causing death in roughly 1300 people per year.
Merck Ramps Up MMR Vaccine Production as Demand Grows
Merck, the sole supplier of the MMR vaccine in the United States, is increasing production to meet growing demand from areas where measles outbreaks are ongoing.
Uganda Tests Preparedness for Ebola as DRC Documents 26 Deaths in 1 Day
As Ebola case counts continue to climb in the ongoing outbreak, emergency preparedness simulations are underway in Uganda.
Third Dose of MMR Vaccine Could Boost Protection Against Mumps
A third dose of the measles-mumps-rubella vaccine may be a safe and effective response to concerns about waning immunity to mumps among young adults.
FDA Approves Dengvaxia Vaccine
The FDA has approved the Dengvaxia vaccine for the prevention of dengue disease in children 9 to 16 years who have laboratory-confirmed previous dengue infection.
Are Frontline Hospitals Ready for a Patient With Ebola?
Designated frontline hospitals were expected to identify, isolate, and hold an Ebola patient for 12-24 hours, but an analysis cites gaps in biopreparedness in these facilities.
Increased Duration of Postop Antimicrobial Prophylaxis Tied to Adverse Events
Surgical-site infection was not found to be associated with duration of prophylaxis, but adjusted odds of AKI and C diff infection increased with each additional day of antimicrobial exposure.
Are Superbugs the New Media Darlings?: Public Health Watch
“60 Minutes” becomes the latest media outlet to cover antibiotic resistance, but are they giving the whole story?
HHS Updates Treatment Guidelines for Children and Adolescents With HIV
Updated guidelines on the treatment and management of HIV in children and adolescents reflect new data on antiretroviral drugs as well as a call for mental health screenings.
FDA Issues Complete Response Letter to Nabriva for Intravenous Fosfomycin
The CRL requests that Nabriva address issues related to facility inspections and manufacturing deficiencies at one of Nabriva’s contract manufacturers prior to the FDA approving the New Drug Application.
Glecaprevir and Pibrentasvir Approved to Treat Hepatitis C in Children
The FDA has approved Mavyret (glecaprevir and pibrentasvir) tablets to treat all 6 genotypes of hepatitis C in children 12 to 17 years.
Popular E-Cigarettes Could Be Contaminated With Microbial Toxins
An investigation by Harvard T.H. Chan School of Public Health found that 27% of sampled e-cigarettes contained traces of endotoxin while 81% contained traces of glucan.
The Latest Guidance on Cryptococcosis Treatment in Solid Organ Transplant Recipients
Here are the most recent recommendations for these tricky fungal infections in solid organ transplant recipients.
US Flu Activity Falls Below Baseline After Longest Flu Season in a Decade
A 21-week-long flu season begins to wind down while investigators find that flu infections in consecutive seasons are more likely in young children.
Takeaways from ECCMID 2019: Part 2
Experts from the fields of microbiology and infectious disease share their biggest takeaways and highlights from ECCMID 2019.
Nicole Cotroneo, BS, on the Potential of Tebipenem to Treat Multidrug-Resistant UTIs
Nicole Cotroneo, BS, discusses her research presented at ECCMID 2019 on the activity of tebipenem against multidrug-resistant urinary tract infection-causing pathogens.